Skip to main content
. 2023 Nov 11;12(22):2608. doi: 10.3390/cells12222608

Table 3.

Protein therapeutics.

Drug Target/Mechanism Experimental System Further Development? Ref.
METRNL Enhances myogenesis (1) BaCl2 TA muscle injury model
(2) Aged male C57BL/6J mice (24–26 mo)
Not assessed in aged mice without injury [127]
GDF11PRO-Fc GDF11 and myostatin inhibitor (1) Adult male mice the (2) mdx model of Duchenne muscular dystrophy Not assessed in aged mice [132]